HomeCompareASNB vs PLD

ASNB vs PLD: Dividend Comparison 2026

ASNB yields 1058.82% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASNB wins by $31071339.60M in total portfolio value
10 years
ASNB
ASNB
● Live price
1058.82%
Share price
$0.85
Annual div
$9.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31071345.51M
Annual income
$26,203,152,977,635.43
Full ASNB calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — ASNB vs PLD

📍 ASNB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASNBPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASNB + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ASNB pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASNB
Annual income on $10K today (after 15% tax)
$90,000.00/yr
After 10yr DRIP, annual income (after tax)
$22,272,680,030,990.11/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, ASNB beats the other by $22,272,675,992,873.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASNB + PLD for your $10,000?

ASNB: 50%PLD: 50%
100% PLD50/50100% ASNB
Portfolio after 10yr
$15535675.71M
Annual income
$13,101,578,864,180.30/yr
Blended yield
84.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ASNB
No analyst data
Altman Z
-0.8
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASNB buys
0
PLD buys
0
No recent congressional trades found for ASNB or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASNBPLD
Forward yield1058.82%3.10%
Annual dividend / share$9.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$31071345.51M$5.91M
Annual income after 10y$26,203,152,977,635.43$4,750,725.19
Total dividends collected$30702285.77M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ASNB vs PLD ($10,000, DRIP)

YearASNB PortfolioASNB Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$116,582$105,882.35$11,241$540.96+$105.3KASNB
2$1,278,389$1,153,646.15$13,019$991.13+$1.27MASNB
3$13,190,644$11,822,767.40$15,801$1,870.97+$13.17MASNB
4$128,122,756$114,008,766.65$20,609$3,701.21+$128.10MASNB
5$1,172,030,327$1,034,938,978.31$29,919$7,867.97+$1172.00MASNB
6$10,102,040,479$8,847,968,029.27$50,631$18,617.74+$10101.99MASNB
7$82,083,001,031$71,273,817,718.63$105,528$51,352.20+$82082.90MASNB
8$629,069,410,336$541,240,599,232.35$287,364$174,449.42+$629069.12MASNB
9$4,549,712,643,140$3,876,608,374,080.81$1,081,760$774,280.77+$4549711.56MASNB
10$31,071,345,505,795$26,203,152,977,635.43$5,908,209$4,750,725.19+$31071339.60MASNB

ASNB vs PLD: Complete Analysis 2026

ASNBStock

EKIMAS Corporation does not have significant operations. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It intends to identify, acquire, or merge with an operating company through an equity-based exchange transaction. The company was formerly known as AdvanSource Biomaterials Corporation and changed its name to EKIMAS Corporation in March 2020. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada.

Full ASNB Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ASNB vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASNB vs SCHDASNB vs JEPIASNB vs OASNB vs KOASNB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.